Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.62 -0.01 (-1.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Biodexa Pharmaceuticals (BDRX) Cash from Discontinued Operations (2017 - 2018)

Updated

Biodexa Pharmaceuticals' Cash from Discontinued Operations was -$1.21 million in the year ended Dec 31, 2019.

Analysis

Biodexa Pharmaceuticals (BDRX) Cash from Discontinued Operations (2017 - 2018) Analysis & Trends

  • The figure for the year ended Dec 31, 2019 marks the highest annual Cash from Discontinued Operations since the year ended Dec 31, 2016.
  • Per Business Quant data, Cash from Discontinued Operations in earlier years was $1.63 million in the year ended Dec 31, 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.87 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Biodexa Pharmaceuticals 39.17 Mn 15.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -6.92 Mn
Dec 31, 2017 17.47 Mn
API Access

Biodexa Pharmaceuticals Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=BDRX&period=max&api_key=YOUR_API_KEY